Are you over 18 and want to see adult content?
More Annotations
![A complete backup of https://minneapolismn.gov](https://www.archivebay.com/archive6/images/1df8ae4f-e4c0-42e8-818e-f40b8ed6150a.png)
A complete backup of https://minneapolismn.gov
Are you over 18 and want to see adult content?
![A complete backup of https://houstonhabitat.org](https://www.archivebay.com/archive6/images/d8a43dd9-6a1d-4b9c-b9ed-9528a8054d5d.png)
A complete backup of https://houstonhabitat.org
Are you over 18 and want to see adult content?
![A complete backup of https://havealook.com.au](https://www.archivebay.com/archive6/images/d4253058-79c4-4306-b71d-3520bc0ecad2.png)
A complete backup of https://havealook.com.au
Are you over 18 and want to see adult content?
![A complete backup of https://worldinferno.com](https://www.archivebay.com/archive6/images/0f92ea15-5a6c-4f6a-8dad-d949bf05d9e2.png)
A complete backup of https://worldinferno.com
Are you over 18 and want to see adult content?
![A complete backup of https://albumcore.ru](https://www.archivebay.com/archive6/images/df26a4d1-f08c-4967-82d6-384beaab991b.png)
A complete backup of https://albumcore.ru
Are you over 18 and want to see adult content?
![A complete backup of https://agipronews.it](https://www.archivebay.com/archive6/images/d43ffcb9-b104-4228-819a-a4636ad54f7e.png)
A complete backup of https://agipronews.it
Are you over 18 and want to see adult content?
![A complete backup of https://psychopoeia.com](https://www.archivebay.com/archive6/images/00047cae-0966-4e53-8766-6635921d98bb.png)
A complete backup of https://psychopoeia.com
Are you over 18 and want to see adult content?
![A complete backup of https://lazaworx.com](https://www.archivebay.com/archive6/images/653068f8-c7e2-4513-8777-3b9c41114f1b.png)
A complete backup of https://lazaworx.com
Are you over 18 and want to see adult content?
![A complete backup of https://lad.gov.lv](https://www.archivebay.com/archive6/images/6d98e4b0-66b6-4596-b939-3b7b5ca618df.png)
A complete backup of https://lad.gov.lv
Are you over 18 and want to see adult content?
![A complete backup of https://spotfolio.com](https://www.archivebay.com/archive6/images/d239eb16-fd0a-4254-9890-79ecb43e50f7.png)
A complete backup of https://spotfolio.com
Are you over 18 and want to see adult content?
![A complete backup of https://instagrowing.net](https://www.archivebay.com/archive6/images/7a059289-2dba-4afb-8c12-6ac49018f673.png)
A complete backup of https://instagrowing.net
Are you over 18 and want to see adult content?
![A complete backup of https://bannerbuzz.com.au](https://www.archivebay.com/archive6/images/7e32233c-31d9-4094-9bf1-0b8d2615e8c5.png)
A complete backup of https://bannerbuzz.com.au
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of mathematicsgre.com](https://www.archivebay.com/archive2/ca4bff77-e2ad-4c13-8f4a-beaf353622b0.png)
A complete backup of mathematicsgre.com
Are you over 18 and want to see adult content?
![A complete backup of windowsdiscussions.com](https://www.archivebay.com/archive2/d7bbcfc2-fe3c-4b5b-b3a7-78a748c87c2a.png)
A complete backup of windowsdiscussions.com
Are you over 18 and want to see adult content?
![A complete backup of iconnutrition.com](https://www.archivebay.com/archive2/4db972a7-6533-4285-a3fa-279901b3e180.png)
A complete backup of iconnutrition.com
Are you over 18 and want to see adult content?
![A complete backup of telecommandeportail.net](https://www.archivebay.com/archive2/1dcfa55d-1372-446b-9428-aa4f9ffdb32b.png)
A complete backup of telecommandeportail.net
Are you over 18 and want to see adult content?
![A complete backup of vriskoapostasi.gr](https://www.archivebay.com/archive2/55b65ff5-662c-47c4-82e8-b1359823c9f5.png)
A complete backup of vriskoapostasi.gr
Are you over 18 and want to see adult content?
![A complete backup of baja92.weebly.com](https://www.archivebay.com/archive2/1841bf85-7fd6-40bf-a773-67418dde89c5.png)
A complete backup of baja92.weebly.com
Are you over 18 and want to see adult content?
![A complete backup of entrecampeonas.com](https://www.archivebay.com/archive2/7ea7bb0c-57ec-48d6-942f-39c8f3cd2aef.png)
A complete backup of entrecampeonas.com
Are you over 18 and want to see adult content?
![A complete backup of americantwoshot.com](https://www.archivebay.com/archive2/68a52f5f-9aac-44ec-8afc-5a7b2c47c30e.png)
A complete backup of americantwoshot.com
Are you over 18 and want to see adult content?
Text
a business update.
MARCH 2021 INVESTOR PRESENTATION NEXT-GENERATION, ULTRA-FAST WIRELESS TECHNOLOGIES WORK TOGETHER TO UNLOCK NEW APPLICATIONS WI-FI 6E Wireless Networks Depend on Each Other To Unlock New Applications CONNECTED CARS EXTENDED REALITY2020 ANNUAL REPORT
CLARUS CORPORATION 2020 Annual Report ANNUAL MEETING The Annual Meeting of Stockholders will be held on Wednesday, June 2, 2021 at 10:00 a.m. Eastern Daylight EFFICACY AND SAFETY OF SELADELPAR IN PRIMARY BILIARY Slides are the property of the author and AASLD. Permission is required from both AASLD and the author for reuse. Efficacy and Safetyof Seladelpar
NAKED BRAND GROUP LIMITED (NASDAQ NAKD) TEAR SHEET Title: Naked Brand Group Limited (Nasdaq NAKD) Tear Sheet Created Date: 6/4/2021 6:03:15 PM SELADELPAR INTERIM DATA PHASE 2 LOW DOSE STUDY IN PBC Seladelpar Phase 2 Low Dose Study in PBC Potential for superior efficacy and better tolerability 2 No safety signal for transaminase elevation or drug-induced itch RF INNOVATION AND THE TRANSITION TO 5G WIRELESS TECHNOLOGY 5 RESONANT ® The emerging definition of 5G envisions dramatic performance improvements in network capacity, mobile connections, latency, cost, data rates and coverage . A RESERVOIR STIMULATION TECHNOLOGY FOR ENHANCED Novas Energy North America, LLC • 2015! PPT Value Proposition • Proven technology – Over 300 wells successfully treated globally! • Stimulation of entire reservoir with pulse generated waves! • Enhanced production through increased permeability & reduced viscosity! • Increase in recovery of oil in place! • Clean perforations and aids in reduction of the skin factor! ENHANCING THE LONGEVITY AND IN VIVO POTENCY OF THERAPEUTIC Precision Medicine. 2015; 2: e989. doi: 10.14800/pm.989; © 2015 by Doron Calo, et al. http://www.smartscitech.com/index.php/pm. Page . of. 8. in vivo
CORPORATE PRESENTATION 2. Safe Harbor Statement. This presentation contains "forward -looking" statements that involve risks, uncertainties and assumptions, and actual results may differ substantially from those projected or expected in the forward -looking statements. CYMABAY REPORTS FOURTH QUARTER AND YEAR END 2020 FINANCIAL CymaBay will host a conference call today at 4:30 p.m. ET to discuss fourth quarter and fiscal year end 2020 financial results and providea business update.
MARCH 2021 INVESTOR PRESENTATION NEXT-GENERATION, ULTRA-FAST WIRELESS TECHNOLOGIES WORK TOGETHER TO UNLOCK NEW APPLICATIONS WI-FI 6E Wireless Networks Depend on Each Other To Unlock New Applications CONNECTED CARS EXTENDED REALITY2020 ANNUAL REPORT
CLARUS CORPORATION 2020 Annual Report ANNUAL MEETING The Annual Meeting of Stockholders will be held on Wednesday, June 2, 2021 at 10:00 a.m. Eastern Daylight EFFICACY AND SAFETY OF SELADELPAR IN PRIMARY BILIARY Slides are the property of the author and AASLD. Permission is required from both AASLD and the author for reuse. Efficacy and Safetyof Seladelpar
NAKED BRAND GROUP LIMITED (NASDAQ NAKD) TEAR SHEET Title: Naked Brand Group Limited (Nasdaq NAKD) Tear Sheet Created Date: 6/4/2021 6:03:15 PM SELADELPAR INTERIM DATA PHASE 2 LOW DOSE STUDY IN PBC Seladelpar Phase 2 Low Dose Study in PBC Potential for superior efficacy and better tolerability 2 No safety signal for transaminase elevation or drug-induced itch RF INNOVATION AND THE TRANSITION TO 5G WIRELESS TECHNOLOGY 5 RESONANT ® The emerging definition of 5G envisions dramatic performance improvements in network capacity, mobile connections, latency, cost, data rates and coverage . A RESERVOIR STIMULATION TECHNOLOGY FOR ENHANCED Novas Energy North America, LLC • 2015! PPT Value Proposition • Proven technology – Over 300 wells successfully treated globally! • Stimulation of entire reservoir with pulse generated waves! • Enhanced production through increased permeability & reduced viscosity! • Increase in recovery of oil in place! • Clean perforations and aids in reduction of the skin factor! ENHANCING THE LONGEVITY AND IN VIVO POTENCY OF THERAPEUTIC Precision Medicine. 2015; 2: e989. doi: 10.14800/pm.989; © 2015 by Doron Calo, et al. http://www.smartscitech.com/index.php/pm. Page . of. 8. in vivo
CORPORATE PRESENTATION 2. Safe Harbor Statement. This presentation contains "forward -looking" statements that involve risks, uncertainties and assumptions, and actual results may differ substantially from those projected or expected in the forward -looking statements. MAY 2021 FIRST QUARTER 2021 EARNINGS Q1 2021 Earnings Presentation NASDAQ: RESN | 10 2nd Milestone Achieved Target performance Packaging Initial Reliability Focus is now on commercialization (high-volume manufacturing of XBAR-based RF filters for 5G) 50% of the prepaid royalties received to-date Represents potential $100M+ annual market opportunity for Resonant EV CHARGING SERVICES 2020 Blink Charging Co. All Rights Reserved. 3 Nasdaq: BLNK, BLNKW Blink Charging Investor Presentation BLINK CHARGING Corporate Highlights Founded in 2009 MINERAL RESOURCE ESTIMATE SUMMARY AND JORC TABLE 1 Table 1: Sampling Techniques and Data Criteria JORC Code explanation Commentary Sampling techniques Resources, is from diamond drill sampling, therefore surface sampling is •Nature and quality of sampling (e.g. cut channels, random chips, or specific specialised industry standard measurement tools appropriate to the minerals under investigation, such as down hole ENHANCING THE LONGEVITY AND IN VIVO POTENCY OF THERAPEUTIC Precision Medicine. 2015; 2: e989. doi: 10.14800/pm.989; © 2015 by Doron Calo, et al. http://www.smartscitech.com/index.php/pm. Page . of. 8. in vivo
SELADELPAR FOR THE TREATMENT OF PRIMARY BILIARY Seladelpar for the Treatment of Primary Biliary Cholangitis: Experience with 25 Cirrhotic Patients Mayo M. J., Bowlus C., Galambos M., Neff G., Trivedi P., Goel A ENABLING CONTINUITY OF CARE FOR PATIENTS, FROM THE CLINIC Investment Highlights. 3. Enabling continuity of patient care from the hospital/clinic into the home by providing durable medical equipment (DME), including ambulatory infusion pumps and related servicesCODE OF CONDUCT
The Macy’s, Inc. Code of Conduct P. 4 About This Code Who is governed by this Code? This Code applies to all Macy’s and Bloomingdale’s colleagues, whether working in stores, centraloffices, support
CAN-FITE PRESENTATION (NYSE American: CANF) (TASE:CFBI) 3 Company Profile •Advanced clinical stage drug development company with a compelling platform technology and robust clinical proof of concept •Small molecule drug products in Phase II and Phase III clinical studies; covered by 15 Patent Families • Successful corporate partnerships and licensingdeals with ~$18 M
TORCHLIGHT ENERGY RESOURCES, INC. Michael Zebrowski Consulting LLC Torchlight Energy Resources, Inc. Orogrande Basin Technical Presentation Confidential to Torchlight Energy Resources, Inc. CONTENT.EQUISOLVE.NET content.equisolve.net INVESTOR PRESENTATION •Global video subscription service (S VOD) @ $11.99/month (Ad Free) • Network of niche channels for an underserved subscriber base with 8,000+ original programs and curated videos • 80+% of content is exclusive to Gaia including worldwide rights • $299 Live Access annual membership launched in June 2019 1 TARGET DEMOGRAPHIC Consumption across channels 55% Female / 45% Male EFFICACY AND SAFETY OF SELADELPAR IN PRIMARY BILIARY Slides are the property of the author and AASLD. Permission is required from both AASLD and the author for reuse. Efficacy and Safetyof Seladelpar
A-054 ORAL DOSING OF ENCOCHLEATED AMPHOTERICIN B (CAMB ABSTRACT Cochleate delivery vehicles have been shown to mediate oral bioavailability for injectable drugs, reduce toxicity, and significantly enhance intracellular drug delivery.Cochleates are stable, lipid-crystal, nano-particles composed of simple, naturally SELADELPAR FOR THE TREATMENT OF PRIMARY BILIARY Seladelpar for the Treatment of Primary Biliary Cholangitis: Experience with 25 Cirrhotic Patients Mayo M. J., Bowlus C., Galambos M., Neff G., Trivedi P., Goel A SELADELPAR INTERIM DATA PHASE 2 LOW DOSE STUDY IN PBC Seladelpar Phase 2 Low Dose Study in PBC Potential for superior efficacy and better tolerability 2 No safety signal for transaminase elevation or drug-induced itch NAKED BRAND GROUP LIMITED (NASDAQ NAKD) TEAR SHEET Title: Naked Brand Group Limited (Nasdaq NAKD) Tear Sheet Created Date: 6/4/2021 6:03:15 PM CORPORATE PRESENTATION 2. Safe Harbor Statement. This presentation contains "forward -looking" statements that involve risks, uncertainties and assumptions, and actual results may differ substantially from those projected or expected in the forward -looking statements. ENHANCING THE LONGEVITY AND IN VIVO POTENCY OF THERAPEUTIC of . in vivo. in vivo PLASMA PULSE TECHNOLOGY (PPT) Novas Energy North America, LLC • 2015 Tool Specifications • Presently only for vertical wells (< 50° deviation), Horizontal system coming in 2016 • Sizes Available: 4.02” (102 mm) OD, 9.02 ft.(2750 mm) length available now 3.50” (89 mm) OD, 9.4 ft. (2865 mm) length final testing in ongoing TORCHLIGHT ENERGY RESOURCES, INC. Michael Zebrowski Consulting LLC Torchlight Energy Resources, Inc. Orogrande Basin Technical Presentation Confidential to Torchlight Energy Resources, Inc. SELADELPAR INTERIM DATA PHASE 2 LOW DOSE STUDY IN PBC Seladelpar Phase 2 Low Dose Study in PBC Potential for superior efficacy and better tolerability 2 No safety signal for transaminase elevation or drug-induced itch EFFICACY AND SAFETY OF SELADELPAR IN PRIMARY BILIARY Slides are the property of the author and AASLD. Permission is required from both AASLD and the author for reuse. Efficacy and Safetyof Seladelpar
ENHANCING THE LONGEVITY AND IN VIVO POTENCY OF THERAPEUTIC of . in vivo. in vivo NAKED BRAND GROUP LIMITED (NASDAQ NAKD) TEAR SHEET Title: Naked Brand Group Limited (Nasdaq NAKD) Tear Sheet Created Date: 6/4/2021 6:03:15 PM A-054 ORAL DOSING OF ENCOCHLEATED AMPHOTERICIN B (CAMB ABSTRACT Cochleate delivery vehicles have been shown to mediate oral bioavailability for injectable drugs, reduce toxicity, and significantly enhance intracellular drug delivery.Cochleates are stable, lipid-crystal, nano-particles composed of simple, naturally TORCHLIGHT ENERGY RESOURCES, INC. Michael Zebrowski Consulting LLC Torchlight Energy Resources, Inc. Orogrande Basin Technical Presentation Confidential to Torchlight Energy Resources, Inc. INVESTOR PRESENTATION •Global video subscription service (S VOD) @ $11.99/month (Ad Free) • Network of niche channels for an underserved subscriber base with 8,000+ original programs and curated videos • 80+% of content is exclusive to Gaia including worldwide rights • $299 Live Access annual membership launched in June 2019 1 TARGET DEMOGRAPHIC Consumption across channels 55% Female / 45% Male CORPORATE PRESENTATION 2. Safe Harbor Statement. This presentation contains "forward -looking" statements that involve risks, uncertainties and assumptions, and actual results may differ substantially from those projected or expected in the forward -looking statements. SELADELPAR FOR THE TREATMENT OF PRIMARY BILIARY Seladelpar for the Treatment of Primary Biliary Cholangitis: Experience with 25 Cirrhotic Patients Mayo M. J., Bowlus C., Galambos M., Neff G., Trivedi P., Goel A PLASMA PULSE TECHNOLOGY (PPT) Novas Energy North America, LLC • 2015 Tool Specifications • Presently only for vertical wells (< 50° deviation), Horizontal system coming in 2016 • Sizes Available: 4.02” (102 mm) OD, 9.02 ft.(2750 mm) length available now 3.50” (89 mm) OD, 9.4 ft. (2865 mm) length final testing in ongoing ENABLING CONTINUITY OF CARE FOR PATIENTS, FROM THE CLINIC Investment Highlights. 3. Enterprise Value * $488M. Market Cap * $450M. Shares Out. 20.3M. 2020 Revenue. $97.4M, Up 20% y/y . 2021 Revenue Guidance. $107-$110M. Providing best -in-class MARCH 2021 INVESTOR PRESENTATION NEXT-GENERATION, ULTRA-FAST WIRELESS TECHNOLOGIES WORK TOGETHER TO UNLOCK NEW APPLICATIONS WI-FI 6E Wireless Networks Depend on Each Other To Unlock New Applications CONNECTED CARS EXTENDED REALITY TONIX PHARMACEUTICALS REPORTS FIRST QUARTER 2021 FINANCIAL Research and development expenses for the first quarter of 2021 were $15.3 million, compared to $4.7 million for the same period in 2020. This increase is predominately due to RF INNOVATION AND THE TRANSITION TO 5G WIRELESS TECHNOLOGY 5 RESONANT ® The emerging definition of 5G envisions dramatic performance improvements in network capacity, mobile connections, latency, cost, data rates and coverage . CODA OCTOPUS GROUP, INC. Coda Octopus Group, Inc. 5 Financial Snapshot *EPS in 2019 reflects the recording of a tax expense of $1,007,354 compared to a tax benefit of $1,754,169 in the 2018 period.CODE OF CONDUCT
The Macy’s, Inc. Code of Conduct P. 4 About This Code Who is governed by this Code? This Code applies to all Macy’s and Bloomingdale’s colleagues, whether working in stores, centraloffices, support
ZYVERSA CORPORATE PRESENTATION ZyVersa Is a Clinical Stage, Specialty Biopharma Company Focused on Inflammatory and Renal Diseases With High Unmet Needs LARGEST DOMESTIC ONSHORE NEW FIELD DISCOVERY IN OVER … FORWARD-LOOKING STATEMENT This presentation of Torchlight Energy (“Torchlight” or “Company”) contains forward-looking statements within the meaning of the federal securities laws. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, and goals, assumption of future events or performance are not2021 GUIDANCE
1 2021 Guidance 2021 Guidance Net sales $19.75 billion to $20.75 billion Increase between 14% and 20% compared to 2020 Digital channel Annual penetration of approximately 35% of net sales Credit card revenues, net Approximately 3% of net sales Gross margin rate Increase by high-single digit percentage points, up to 37% SG&A expense rate(revised)
PREVIOUS ADDRESS CURRENT ADDRESS change of address request form previous address current address _____ _____ _____ _____ _____ _____ _____ _____ _____ _____ signature: _____ INVESTOR PRESENTATION •Global video subscription service (S VOD) @ $11.99/month (Ad Free) • Network of niche channels for an underserved subscriber base with 8,000+ original programs and curated videos • 80+% of content is exclusive to Gaia including worldwide rights • $299 Live Access annual membership launched in June 2019 1 TARGET DEMOGRAPHIC Consumption across channels 55% Female / 45% Male EFFICACY AND SAFETY OF SELADELPAR IN PRIMARY BILIARY Slides are the property of the author and AASLD. Permission is required from both AASLD and the author for reuse. Efficacy and Safetyof Seladelpar
A-054 ORAL DOSING OF ENCOCHLEATED AMPHOTERICIN B (CAMB ABSTRACT Cochleate delivery vehicles have been shown to mediate oral bioavailability for injectable drugs, reduce toxicity, and significantly enhance intracellular drug delivery.Cochleates are stable, lipid-crystal, nano-particles composed of simple, naturally SELADELPAR FOR THE TREATMENT OF PRIMARY BILIARY Seladelpar for the Treatment of Primary Biliary Cholangitis: Experience with 25 Cirrhotic Patients Mayo M. J., Bowlus C., Galambos M., Neff G., Trivedi P., Goel A SELADELPAR INTERIM DATA PHASE 2 LOW DOSE STUDY IN PBC Seladelpar Phase 2 Low Dose Study in PBC Potential for superior efficacy and better tolerability 2 No safety signal for transaminase elevation or drug-induced itch NAKED BRAND GROUP LIMITED (NASDAQ NAKD) TEAR SHEET Title: Naked Brand Group Limited (Nasdaq NAKD) Tear Sheet Created Date: 6/4/2021 6:03:15 PM CORPORATE PRESENTATION 2. Safe Harbor Statement. This presentation contains "forward -looking" statements that involve risks, uncertainties and assumptions, and actual results may differ substantially from those projected or expected in the forward -looking statements. ENHANCING THE LONGEVITY AND IN VIVO POTENCY OF THERAPEUTIC of . in vivo. in vivo PLASMA PULSE TECHNOLOGY (PPT) Novas Energy North America, LLC • 2015 Tool Specifications • Presently only for vertical wells (< 50° deviation), Horizontal system coming in 2016 • Sizes Available: 4.02” (102 mm) OD, 9.02 ft.(2750 mm) length available now 3.50” (89 mm) OD, 9.4 ft. (2865 mm) length final testing in ongoing TORCHLIGHT ENERGY RESOURCES, INC. Michael Zebrowski Consulting LLC Torchlight Energy Resources, Inc. Orogrande Basin Technical Presentation Confidential to Torchlight Energy Resources, Inc. INVESTOR PRESENTATION •Global video subscription service (S VOD) @ $11.99/month (Ad Free) • Network of niche channels for an underserved subscriber base with 8,000+ original programs and curated videos • 80+% of content is exclusive to Gaia including worldwide rights • $299 Live Access annual membership launched in June 2019 1 TARGET DEMOGRAPHIC Consumption across channels 55% Female / 45% Male EFFICACY AND SAFETY OF SELADELPAR IN PRIMARY BILIARY Slides are the property of the author and AASLD. Permission is required from both AASLD and the author for reuse. Efficacy and Safetyof Seladelpar
A-054 ORAL DOSING OF ENCOCHLEATED AMPHOTERICIN B (CAMB ABSTRACT Cochleate delivery vehicles have been shown to mediate oral bioavailability for injectable drugs, reduce toxicity, and significantly enhance intracellular drug delivery.Cochleates are stable, lipid-crystal, nano-particles composed of simple, naturally SELADELPAR FOR THE TREATMENT OF PRIMARY BILIARY Seladelpar for the Treatment of Primary Biliary Cholangitis: Experience with 25 Cirrhotic Patients Mayo M. J., Bowlus C., Galambos M., Neff G., Trivedi P., Goel A SELADELPAR INTERIM DATA PHASE 2 LOW DOSE STUDY IN PBC Seladelpar Phase 2 Low Dose Study in PBC Potential for superior efficacy and better tolerability 2 No safety signal for transaminase elevation or drug-induced itch NAKED BRAND GROUP LIMITED (NASDAQ NAKD) TEAR SHEET Title: Naked Brand Group Limited (Nasdaq NAKD) Tear Sheet Created Date: 6/4/2021 6:03:15 PM CORPORATE PRESENTATION 2. Safe Harbor Statement. This presentation contains "forward -looking" statements that involve risks, uncertainties and assumptions, and actual results may differ substantially from those projected or expected in the forward -looking statements. ENHANCING THE LONGEVITY AND IN VIVO POTENCY OF THERAPEUTIC of . in vivo. in vivo PLASMA PULSE TECHNOLOGY (PPT) Novas Energy North America, LLC • 2015 Tool Specifications • Presently only for vertical wells (< 50° deviation), Horizontal system coming in 2016 • Sizes Available: 4.02” (102 mm) OD, 9.02 ft.(2750 mm) length available now 3.50” (89 mm) OD, 9.4 ft. (2865 mm) length final testing in ongoing TORCHLIGHT ENERGY RESOURCES, INC. Michael Zebrowski Consulting LLC Torchlight Energy Resources, Inc. Orogrande Basin Technical Presentation Confidential to Torchlight Energy Resources, Inc. ENABLING CONTINUITY OF CARE FOR PATIENTS, FROM THE CLINIC Investment Highlights. 3. Enterprise Value * $488M. Market Cap * $450M. Shares Out. 20.3M. 2020 Revenue. $97.4M, Up 20% y/y . 2021 Revenue Guidance. $107-$110M. Providing best -in-class MARCH 2021 INVESTOR PRESENTATION NEXT-GENERATION, ULTRA-FAST WIRELESS TECHNOLOGIES WORK TOGETHER TO UNLOCK NEW APPLICATIONS WI-FI 6E Wireless Networks Depend on Each Other To Unlock New Applications CONNECTED CARS EXTENDED REALITY TONIX PHARMACEUTICALS REPORTS FIRST QUARTER 2021 FINANCIAL Research and development expenses for the first quarter of 2021 were $15.3 million, compared to $4.7 million for the same period in 2020. This increase is predominately due to RF INNOVATION AND THE TRANSITION TO 5G WIRELESS TECHNOLOGY 5 RESONANT ® The emerging definition of 5G envisions dramatic performance improvements in network capacity, mobile connections, latency, cost, data rates and coverage . CODA OCTOPUS GROUP, INC. Coda Octopus Group, Inc. 5 Financial Snapshot *EPS in 2019 reflects the recording of a tax expense of $1,007,354 compared to a tax benefit of $1,754,169 in the 2018 period.CODE OF CONDUCT
The Macy’s, Inc. Code of Conduct P. 4 About This Code Who is governed by this Code? This Code applies to all Macy’s and Bloomingdale’s colleagues, whether working in stores, centraloffices, support
ZYVERSA CORPORATE PRESENTATION ZyVersa Is a Clinical Stage, Specialty Biopharma Company Focused on Inflammatory and Renal Diseases With High Unmet Needs LARGEST DOMESTIC ONSHORE NEW FIELD DISCOVERY IN OVER … FORWARD-LOOKING STATEMENT This presentation of Torchlight Energy (“Torchlight” or “Company”) contains forward-looking statements within the meaning of the federal securities laws. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, and goals, assumption of future events or performance are not2021 GUIDANCE
1 2021 Guidance 2021 Guidance Net sales $19.75 billion to $20.75 billion Increase between 14% and 20% compared to 2020 Digital channel Annual penetration of approximately 35% of net sales Credit card revenues, net Approximately 3% of net sales Gross margin rate Increase by high-single digit percentage points, up to 37% SG&A expense rate(revised)
PREVIOUS ADDRESS CURRENT ADDRESS change of address request form previous address current address _____ _____ _____ _____ _____ _____ _____ _____ _____ _____ signature: _____ CYMABAY REPORTS FOURTH QUARTER AND YEAR END 2020 FINANCIAL CymaBay will host a conference call today at 4:30 p.m. ET to discuss fourth quarter and fiscal year end 2020 financial results and providea business update.
MARCH 2021 INVESTOR PRESENTATION NEXT-GENERATION, ULTRA-FAST WIRELESS TECHNOLOGIES WORK TOGETHER TO UNLOCK NEW APPLICATIONS WI-FI 6E Wireless Networks Depend on Each Other To Unlock New Applications CONNECTED CARS EXTENDED REALITY EFFICACY AND SAFETY OF SELADELPAR IN PRIMARY BILIARY Slides are the property of the author and AASLD. Permission is required from both AASLD and the author for reuse. Efficacy and Safetyof Seladelpar
SELADELPAR FOR THE TREATMENT OF PRIMARY BILIARY Seladelpar for the Treatment of Primary Biliary Cholangitis: Experience with 25 Cirrhotic Patients Mayo M. J., Bowlus C., Galambos M., Neff G., Trivedi P., Goel A A-054 ORAL DOSING OF ENCOCHLEATED AMPHOTERICIN B (CAMB ABSTRACT Cochleate delivery vehicles have been shown to mediate oral bioavailability for injectable drugs, reduce toxicity, and significantly enhance intracellular drug delivery.Cochleates are stable, lipid-crystal, nano-particles composed of simple, naturally SELADELPAR INTERIM DATA PHASE 2 LOW DOSE STUDY IN PBC Seladelpar Phase 2 Low Dose Study in PBC Potential for superior efficacy and better tolerability 2 No safety signal for transaminase elevation or drug-induced itch NAKED BRAND GROUP LIMITED (NASDAQ NAKD) TEAR SHEET Title: Naked Brand Group Limited (Nasdaq NAKD) Tear Sheet Created Date: 5/31/2021 6:03:13 PM CORPORATE PRESENTATION 2. Safe Harbor Statement. This presentation contains "forward -looking" statements that involve risks, uncertainties and assumptions, and actual results may differ substantially from those projected or expected in the forward -looking statements. PLASMA PULSE TECHNOLOGY (PPT)PLASMA PULSE TECHNOLOGYPLASMA PULSE TECHNOLOGY FRACKINGPLASMA PULSE ENGINEPLASMA PULSE RIFLEPLASMA PULSE FINALEPLASMA AIR ION GENERATOR Novas Energy North America, LLC • 2015 Tool Specifications • Presently only for vertical wells (< 50° deviation), Horizontal system coming in 2016 • Sizes Available: 4.02” (102 mm) OD, 9.02 ft.(2750 mm) length available now 3.50” (89 mm) OD, 9.4 ft. (2865 mm) length final testing in ongoing TORCHLIGHT ENERGY RESOURCES, INC. Michael Zebrowski Consulting LLC Torchlight Energy Resources, Inc. Orogrande Basin Technical Presentation Confidential to Torchlight Energy Resources, Inc. CYMABAY REPORTS FOURTH QUARTER AND YEAR END 2020 FINANCIAL CymaBay will host a conference call today at 4:30 p.m. ET to discuss fourth quarter and fiscal year end 2020 financial results and providea business update.
MARCH 2021 INVESTOR PRESENTATION NEXT-GENERATION, ULTRA-FAST WIRELESS TECHNOLOGIES WORK TOGETHER TO UNLOCK NEW APPLICATIONS WI-FI 6E Wireless Networks Depend on Each Other To Unlock New Applications CONNECTED CARS EXTENDED REALITY EFFICACY AND SAFETY OF SELADELPAR IN PRIMARY BILIARY Slides are the property of the author and AASLD. Permission is required from both AASLD and the author for reuse. Efficacy and Safetyof Seladelpar
SELADELPAR FOR THE TREATMENT OF PRIMARY BILIARY Seladelpar for the Treatment of Primary Biliary Cholangitis: Experience with 25 Cirrhotic Patients Mayo M. J., Bowlus C., Galambos M., Neff G., Trivedi P., Goel A A-054 ORAL DOSING OF ENCOCHLEATED AMPHOTERICIN B (CAMB ABSTRACT Cochleate delivery vehicles have been shown to mediate oral bioavailability for injectable drugs, reduce toxicity, and significantly enhance intracellular drug delivery.Cochleates are stable, lipid-crystal, nano-particles composed of simple, naturally SELADELPAR INTERIM DATA PHASE 2 LOW DOSE STUDY IN PBC Seladelpar Phase 2 Low Dose Study in PBC Potential for superior efficacy and better tolerability 2 No safety signal for transaminase elevation or drug-induced itch NAKED BRAND GROUP LIMITED (NASDAQ NAKD) TEAR SHEET Title: Naked Brand Group Limited (Nasdaq NAKD) Tear Sheet Created Date: 5/31/2021 6:03:13 PM CORPORATE PRESENTATION 2. Safe Harbor Statement. This presentation contains "forward -looking" statements that involve risks, uncertainties and assumptions, and actual results may differ substantially from those projected or expected in the forward -looking statements. PLASMA PULSE TECHNOLOGY (PPT)PLASMA PULSE TECHNOLOGYPLASMA PULSE TECHNOLOGY FRACKINGPLASMA PULSE ENGINEPLASMA PULSE RIFLEPLASMA PULSE FINALEPLASMA AIR ION GENERATOR Novas Energy North America, LLC • 2015 Tool Specifications • Presently only for vertical wells (< 50° deviation), Horizontal system coming in 2016 • Sizes Available: 4.02” (102 mm) OD, 9.02 ft.(2750 mm) length available now 3.50” (89 mm) OD, 9.4 ft. (2865 mm) length final testing in ongoing TORCHLIGHT ENERGY RESOURCES, INC. Michael Zebrowski Consulting LLC Torchlight Energy Resources, Inc. Orogrande Basin Technical Presentation Confidential to Torchlight Energy Resources, Inc. ENABLING CONTINUITY OF CARE FOR PATIENTS, FROM THE CLINIC Investment Highlights. 3. Enterprise Value * $488M. Market Cap * $450M. Shares Out. 20.3M. 2020 Revenue. $97.4M, Up 20% y/y . 2021 Revenue Guidance. $107-$110M. Providing best -in-class 02-26-21 ENERGOUS 20210225 430PME Energous Corporation Q4 2020 Financial Results Conference Call Thursday, February 25, 2021, 4:30 PM Eastern CORPORATE PARTICIPANTS Steve Rizzone - Chief Executive Officer Brian Sereda - Senior Vice President, Chief Financial Officer Mike Bishop - Investor Relations INTRANASAL (IN) OXYTOCIN RELIEVES PAIN AND DEPRESSIVE 2020 Tonix Pharmaceuticals Holding Corp. 1 July 2020. Shashidhar H Kori, MD, FAHS, David Yeomans, PhD, Michael Klukinov, PhD. Version P0238 7-29-20 (Doc 0676) ZYVERSA CORPORATE PRESENTATION ZyVersa Is a Clinical Stage, Specialty Biopharma Company Focused on Inflammatory and Renal Diseases With High Unmet Needs CONTENT.EQUISOLVE.NET content.equisolve.net TRCH-DEF14A PROXY STATEMENT-2020-B-CLEAN 5hyrfdwlrq ri 3ur[lhv 7kh sur[\ pd\ eh uhyrnhg e\ wkh vwrfnkroghu dw dq\ wlph ehiruh d yrwh lv wdnhq e\ qrwli\lqj rxu 3uhvlghqw lq zulwlqj dw wkh dgguhvv ri 7rufkoljkw (qhuj\ 5hvrxufhv ,qf jlyhq deryh e\ h[hfxwlqj d qhz sur[\ ehdulqj d TORCHLIGHT ENERGY RESOURCES, INC. Michael Zebrowski Consulting LLC Torchlight Energy Resources, Inc. Geosteering Geologic Report Maverick A35 #1H Penn Pay Cycle 4 Lateralwellbore
LARGEST DOMESTIC ONSHORE NEW FIELD DISCOVERY IN OVER … FORWARD-LOOKING STATEMENT This presentation of Torchlight Energy (“Torchlight” or “Company”) contains forward-looking statements within the meaning of the federal securities laws. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, and goals, assumption of future events or performance are not PHONE: 972 3 924 1114 HTTP://WWW.CANFITE.COM COMPANY Can-Fite BioPharma Ltd. 10 Bareket Street Kiryat Matalon Petah Tikva, 4951778, Israel Phone: 972 3 924 1114 http://www.canfite.com CompanyOverview: Can-Fite
CANTABIO AND GARDEDAM THERAPEUTICS COMPLETE MERGER TO returns for investors and we are very excited about taking the company forward.” About Cantabio Pharmaceuticals Inc Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology companyfocusing on
CYMABAY REPORTS FOURTH QUARTER AND YEAR END 2020 FINANCIAL CymaBay will host a conference call today at 4:30 p.m. ET to discuss fourth quarter and fiscal year end 2020 financial results and providea business update.
MARCH 2021 INVESTOR PRESENTATION NEXT-GENERATION, ULTRA-FAST WIRELESS TECHNOLOGIES WORK TOGETHER TO UNLOCK NEW APPLICATIONS WI-FI 6E Wireless Networks Depend on Each Other To Unlock New Applications CONNECTED CARS EXTENDED REALITY EFFICACY AND SAFETY OF SELADELPAR IN PRIMARY BILIARY Slides are the property of the author and AASLD. Permission is required from both AASLD and the author for reuse. Efficacy and Safetyof Seladelpar
SELADELPAR FOR THE TREATMENT OF PRIMARY BILIARY Seladelpar for the Treatment of Primary Biliary Cholangitis: Experience with 25 Cirrhotic Patients Mayo M. J., Bowlus C., Galambos M., Neff G., Trivedi P., Goel A A-054 ORAL DOSING OF ENCOCHLEATED AMPHOTERICIN B (CAMB ABSTRACT Cochleate delivery vehicles have been shown to mediate oral bioavailability for injectable drugs, reduce toxicity, and significantly enhance intracellular drug delivery.Cochleates are stable, lipid-crystal, nano-particles composed of simple, naturally SELADELPAR INTERIM DATA PHASE 2 LOW DOSE STUDY IN PBC Seladelpar Phase 2 Low Dose Study in PBC Potential for superior efficacy and better tolerability 2 No safety signal for transaminase elevation or drug-induced itch NAKED BRAND GROUP LIMITED (NASDAQ NAKD) TEAR SHEET Title: Naked Brand Group Limited (Nasdaq NAKD) Tear Sheet Created Date: 5/31/2021 6:03:13 PM CORPORATE PRESENTATION 2. Safe Harbor Statement. This presentation contains "forward -looking" statements that involve risks, uncertainties and assumptions, and actual results may differ substantially from those projected or expected in the forward -looking statements. PLASMA PULSE TECHNOLOGY (PPT)PLASMA PULSE TECHNOLOGYPLASMA PULSE TECHNOLOGY FRACKINGPLASMA PULSE ENGINEPLASMA PULSE RIFLEPLASMA PULSE FINALEPLASMA AIR ION GENERATOR Novas Energy North America, LLC • 2015 Tool Specifications • Presently only for vertical wells (< 50° deviation), Horizontal system coming in 2016 • Sizes Available: 4.02” (102 mm) OD, 9.02 ft.(2750 mm) length available now 3.50” (89 mm) OD, 9.4 ft. (2865 mm) length final testing in ongoing TORCHLIGHT ENERGY RESOURCES, INC. Michael Zebrowski Consulting LLC Torchlight Energy Resources, Inc. Orogrande Basin Technical Presentation Confidential to Torchlight Energy Resources, Inc. CYMABAY REPORTS FOURTH QUARTER AND YEAR END 2020 FINANCIAL CymaBay will host a conference call today at 4:30 p.m. ET to discuss fourth quarter and fiscal year end 2020 financial results and providea business update.
MARCH 2021 INVESTOR PRESENTATION NEXT-GENERATION, ULTRA-FAST WIRELESS TECHNOLOGIES WORK TOGETHER TO UNLOCK NEW APPLICATIONS WI-FI 6E Wireless Networks Depend on Each Other To Unlock New Applications CONNECTED CARS EXTENDED REALITY EFFICACY AND SAFETY OF SELADELPAR IN PRIMARY BILIARY Slides are the property of the author and AASLD. Permission is required from both AASLD and the author for reuse. Efficacy and Safetyof Seladelpar
SELADELPAR FOR THE TREATMENT OF PRIMARY BILIARY Seladelpar for the Treatment of Primary Biliary Cholangitis: Experience with 25 Cirrhotic Patients Mayo M. J., Bowlus C., Galambos M., Neff G., Trivedi P., Goel A A-054 ORAL DOSING OF ENCOCHLEATED AMPHOTERICIN B (CAMB ABSTRACT Cochleate delivery vehicles have been shown to mediate oral bioavailability for injectable drugs, reduce toxicity, and significantly enhance intracellular drug delivery.Cochleates are stable, lipid-crystal, nano-particles composed of simple, naturally SELADELPAR INTERIM DATA PHASE 2 LOW DOSE STUDY IN PBC Seladelpar Phase 2 Low Dose Study in PBC Potential for superior efficacy and better tolerability 2 No safety signal for transaminase elevation or drug-induced itch NAKED BRAND GROUP LIMITED (NASDAQ NAKD) TEAR SHEET Title: Naked Brand Group Limited (Nasdaq NAKD) Tear Sheet Created Date: 5/31/2021 6:03:13 PM CORPORATE PRESENTATION 2. Safe Harbor Statement. This presentation contains "forward -looking" statements that involve risks, uncertainties and assumptions, and actual results may differ substantially from those projected or expected in the forward -looking statements. PLASMA PULSE TECHNOLOGY (PPT)PLASMA PULSE TECHNOLOGYPLASMA PULSE TECHNOLOGY FRACKINGPLASMA PULSE ENGINEPLASMA PULSE RIFLEPLASMA PULSE FINALEPLASMA AIR ION GENERATOR Novas Energy North America, LLC • 2015 Tool Specifications • Presently only for vertical wells (< 50° deviation), Horizontal system coming in 2016 • Sizes Available: 4.02” (102 mm) OD, 9.02 ft.(2750 mm) length available now 3.50” (89 mm) OD, 9.4 ft. (2865 mm) length final testing in ongoing TORCHLIGHT ENERGY RESOURCES, INC. Michael Zebrowski Consulting LLC Torchlight Energy Resources, Inc. Orogrande Basin Technical Presentation Confidential to Torchlight Energy Resources, Inc. ENABLING CONTINUITY OF CARE FOR PATIENTS, FROM THE CLINIC Investment Highlights. 3. Enterprise Value * $488M. Market Cap * $450M. Shares Out. 20.3M. 2020 Revenue. $97.4M, Up 20% y/y . 2021 Revenue Guidance. $107-$110M. Providing best -in-class 02-26-21 ENERGOUS 20210225 430PME Energous Corporation Q4 2020 Financial Results Conference Call Thursday, February 25, 2021, 4:30 PM Eastern CORPORATE PARTICIPANTS Steve Rizzone - Chief Executive Officer Brian Sereda - Senior Vice President, Chief Financial Officer Mike Bishop - Investor Relations INTRANASAL (IN) OXYTOCIN RELIEVES PAIN AND DEPRESSIVE 2020 Tonix Pharmaceuticals Holding Corp. 1 July 2020. Shashidhar H Kori, MD, FAHS, David Yeomans, PhD, Michael Klukinov, PhD. Version P0238 7-29-20 (Doc 0676) ZYVERSA CORPORATE PRESENTATION ZyVersa Is a Clinical Stage, Specialty Biopharma Company Focused on Inflammatory and Renal Diseases With High Unmet Needs CONTENT.EQUISOLVE.NET content.equisolve.net TRCH-DEF14A PROXY STATEMENT-2020-B-CLEAN 5hyrfdwlrq ri 3ur[lhv 7kh sur[\ pd\ eh uhyrnhg e\ wkh vwrfnkroghu dw dq\ wlph ehiruh d yrwh lv wdnhq e\ qrwli\lqj rxu 3uhvlghqw lq zulwlqj dw wkh dgguhvv ri 7rufkoljkw (qhuj\ 5hvrxufhv ,qf jlyhq deryh e\ h[hfxwlqj d qhz sur[\ ehdulqj d TORCHLIGHT ENERGY RESOURCES, INC. Michael Zebrowski Consulting LLC Torchlight Energy Resources, Inc. Geosteering Geologic Report Maverick A35 #1H Penn Pay Cycle 4 Lateralwellbore
LARGEST DOMESTIC ONSHORE NEW FIELD DISCOVERY IN OVER … FORWARD-LOOKING STATEMENT This presentation of Torchlight Energy (“Torchlight” or “Company”) contains forward-looking statements within the meaning of the federal securities laws. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, and goals, assumption of future events or performance are not PHONE: 972 3 924 1114 HTTP://WWW.CANFITE.COM COMPANY Can-Fite BioPharma Ltd. 10 Bareket Street Kiryat Matalon Petah Tikva, 4951778, Israel Phone: 972 3 924 1114 http://www.canfite.com CompanyOverview: Can-Fite
CANTABIO AND GARDEDAM THERAPEUTICS COMPLETE MERGER TO returns for investors and we are very excited about taking the company forward.” About Cantabio Pharmaceuticals Inc Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology companyfocusing on
NAVIGATE EQUISOLVE
* Corporate Websites* IR Websites
* Video
* Request Demo
* About
* Careers
* Contact
* Request Demo
* Support
* Client Login
EQUISOLVE RESOURCES
* About
* Careers
* Contact
* Support
* Client Login
REQUEST DEMO
Let us show you what your IR website is capable of* Required Fields
First Name*
Last Name*
Company
Email*
Phone
* Corporate Website
* IR Website
* Video Production
* Webcasting
* Newswire
Captcha
Let's Talk
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Serviceapply.
AN AWARD-WINNING
DIGITAL AGENCY FOR PUBLIC COMPANIES More Than 200 MarCom Awards Under Our Belt... and CountingCorporate Websites
Investor Websites Scroll HAPPY CLIENTS • HAPPY VISITORS • HAPPY INVESTORS We know that a website is more than just a page with words, it’s a reflection of your company Our client's websites inspire investor confidence .slide" data-cycle-swipe="true" data-cycle-swipe-fx="scrollHorz" data-cycle-timeout="0" data-cycle-prev="> .prev" data-cycle-next="> .next" data-cycle-log="false" style="position: relative;"> NYSE: M • Corporate WebsiteView Site
EQUISOLVE CLIENTS
Prev Next
NYSE: M • Corporate WebsiteView Site
NYSE: VFC • Corporate WebsiteView Site
NYSE: KTB • Corporate WebsiteView Site
Nasdaq Global Select: MIK • IR WebsiteView Site
NYSE: HTZ
View Site
NYSE: SKX • IR WebsiteView Site
NYSE: LSI • IR WebsiteView Site
NYSE: TLRD • Corporate WebsiteView Site
NYSE MKT: JOB • Corporate WebsiteView Site
NASDAQ: GPOR • Corporate WebsiteView Site
NASDAQ: TGEN • Corporate WebsiteView Site
NASDAQ: CPST • Corporate WebsiteView Site
NASDAQ: ARTX • Corporate WebsiteView Site
NYSE: DLA • Corporate WebsiteView Site
NASDAQ: WSTL • Corporate WebsiteView Site
ABOUT EQUISOLVE
Equisolve is an award-winning digital agency providing website development and ongoing website management services to public companies. Our services and platform combine both corporate and investor website into one unified digital presence including the website, IR website and shareholder communication. No longer is it required to have separate vendors for both the investor and corporatewebsite.
Learn More
Careers
WE WORK WITH PUBLIC COMPANIES LARGE AND SMALL CONTACT US TODAY AND RETHINK HOW YOU INTERACT WITH YOUR INVESTORS* Required Fields
First Name*
Last Name*
Company
Email*
Phone
Corporate Website IR Website Video Production Webcasting NewswireCaptcha Let's Talk
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Serviceapply.
2021 Equisolve Privacy Notice Terms of Service GDPR/CCPA Data ProtectionAddendum Sitemap
Other Services Careers White PapersResources
Contact Equisolve on LinkedIn Equisolve on Twitter Equisolve on Facebook Olark launch button clip path Envelope Iconenvelope to indicate the site is offlineContact usCONTACT US!
We're not around, but we'd love to chat another time. powered by Olark LogoDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0